$3.28-5.75%
2026-10-06 closeRelmada Therapeutics's close-price date is 2026-10-06. Trailing 12 months PER is -6.0×. Latest quarter PBR is 1.78×. The comparison sector is Healthcare.
Sector grades
B+
Overall: Healthcare 252/740 · top 34%
Factor composite · relative position in sector
Valuation bands — last annual report
The four key numbers use trailing earnings and the latest quarterly book value when available. These bands use the last annual report, so the values can differ.
PER — · PBR 6.77 — own-history percentile 48/100 · 16/100
Open self-history band
PER48/100
PBR16/100
Factual information · not investment advice
Quantus Signal · live data · not investment advice · Privacy Policy